Determining Elements of Anti-Fungal Immunity in BURN Patients
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Feb 10, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Determining Elements of Anti-Fungal Immunity in BURN Patients," aims to understand why some burn patients develop serious fungal infections while others do not. Fungal infections can be very dangerous, especially for patients with severe burns, and the researchers want to learn more about how burn injuries affect the immune system's ability to fight these infections. The study will include adult patients aged 18 and older who have suffered significant burns covering at least 15% of their body and who are admitted to the hospital within four days of their injury.
If eligible, participants will be asked to join the study and share information about their health and recovery. They will not be able to participate if they are pregnant, oppose the study, or if there are decisions made about limiting their medical care. Although the trial is not yet recruiting patients, it represents an important step towards improving treatment and outcomes for burn patients at risk of fungal infections.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Burn patients
- • Adult patients ≥ 18 years old
- • Admission \< 4 days following burn injury
- • Total burn surface Area ≥ 15%
- • Non opposition of the patient or his/her relatives to the research
- • Affiliation to social security or any health insurance
- Exclusion Criteria:
- • Pregnancy
- • Opposition of the patient or his/her relatives
- • Decision not to resuscitate or to limit or stop active therapies
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported